What Are the Guidelines for Using ESAs in Cancer Patients?
Various medical organizations, including the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH), have developed guidelines for the use of ESAs in cancer patients. These guidelines typically recommend that ESAs be used only for the treatment of anemia caused by chemotherapy and not for anemia caused by the cancer itself. Furthermore, the decision to use ESAs should be based on a careful assessment of the patientâs condition, the type of cancer, and the potential risks and benefits.
